MET and pancreatic ductal adenocarcinoma: Tumor‐intrinsic programmed cell death 1 (PD‐1) has been shown to activate the mesenchymal epithelial transition factor (MET) pathway via its phosphorylation in pancreatic ductal adenocarcinoma (PDAC).